189 related articles for article (PubMed ID: 11661566)
1. Freedom of choice in medical treatment: reconsidering the efficacy requirement of the FDCA.
Clinite BJ
Loyola Univ Chic Law J; 1977; 9(1):205-26. PubMed ID: 11661566
[No Abstract] [Full Text] [Related]
2. Laetrile: statutory and constitutional limitations on the regulation of ineffective drugs.
Univ PA Law Rev; 1978 Nov; 127(1):233-72. PubMed ID: 11661627
[No Abstract] [Full Text] [Related]
3. The uncertain application of the right of privacy in personal medical decisions: the Laetrile cases.
Christensen J
Ohio State Law J; 1981; 42(2):523-50. PubMed ID: 11649547
[No Abstract] [Full Text] [Related]
4. The Laetrile controversy: freedom of choice in medicines urged.
Link M
Congr Q Wkly Rep; 1977 Jul; 35(27):1346-8. PubMed ID: 11661613
[No Abstract] [Full Text] [Related]
5. Laetrile: individual choice for cancer patients.
Block RE
Rev Law Soc Change; 1978; 7(2):313-34. PubMed ID: 11661706
[No Abstract] [Full Text] [Related]
6. Laetrile and the privacy right in decisional responsibility.
Volzer HJ
Med Trial Tech Q; 1980; 27(4):395-429. PubMed ID: 11662802
[No Abstract] [Full Text] [Related]
7. People v. Privitera: the right to prescribe and use Laetrile.
Brandt EK
West State Univ Law Rev; 1978; 5(2):201-229. PubMed ID: 11661590
[No Abstract] [Full Text] [Related]
8. Private rights to adulterated/misbranded articles.
McMonagle L
AIDS Public Policy J; 1987; 2(2):33-49. PubMed ID: 11650029
[No Abstract] [Full Text] [Related]
9. Laetrile: the battle moves into the courtroom.
Schwartz RL
Am Bar Assoc J; 1979 Feb; 65():224-8. PubMed ID: 11661617
[No Abstract] [Full Text] [Related]
10. Laetrile's message to the FDA.
Spivak J
Wall St J (East Ed); 1977 Jul; ():12. PubMed ID: 11649063
[No Abstract] [Full Text] [Related]
11. People v. Privitera.
Olson RE
Human Rights; 1977; 6(3):314-8. PubMed ID: 11661736
[No Abstract] [Full Text] [Related]
12. The judicial dilemma of Laetrile and a possible solution.
Pendergast WR
Mercer Law Rev; 1979; 30(3):573-84. PubMed ID: 11661827
[No Abstract] [Full Text] [Related]
13. The right of privacy in choosing medical treatment: should terminally ill persons have access to drugs not yet approved by the Food and Drug Administration?
Power SH
John Marshall Law Rev; 1987; 20(4):693-714. PubMed ID: 11650094
[No Abstract] [Full Text] [Related]
14. Governmental regulation of heart transplantation and the right to privacy.
Merriken K; Overcast TD
J Contemp Law; 1985; 11(2):481-514. PubMed ID: 11656659
[No Abstract] [Full Text] [Related]
15. Regulating Laetrile: constitutional and statutory implications.
Patton-Hulce VR
Univ Dayton Law Rev; 1980; 5(1):155-76. PubMed ID: 11661910
[No Abstract] [Full Text] [Related]
16. Making experimental drugs available for AIDS treatment.
Krim M
AIDS Public Policy J; 1987; 2(2):1-5. PubMed ID: 11650026
[No Abstract] [Full Text] [Related]
17. Supreme Court enters quarrel over Laetrile.
Mintz M
Washington Post; 1979 Jan; ():A1+. PubMed ID: 11648744
[No Abstract] [Full Text] [Related]
18. Regulation of drug treatments for HIV and AIDS: a contractarian model of access.
Salbu SR
Yale J Regul; 1994; 11(2):401-53. PubMed ID: 11660141
[No Abstract] [Full Text] [Related]
19. Health information privacy.
Gostin LO
Cornell Law Rev; 1995 Mar; 80(3):451-528. PubMed ID: 11660159
[No Abstract] [Full Text] [Related]
20. FDA treatment use regulations: a compassionate response.
Weitzman SA; Marcy T
AIDS Public Policy J; 1987; 2(2):22-32. PubMed ID: 11650028
[No Abstract] [Full Text] [Related]
[Next] [New Search]
